Natural killer cell-target cell interactions

Current Opinion in Cell Biology

Volumn 9, Issue 5, 1997, Pages 667-673

  Timonen, Tuomo ^a   Helander, Tuula S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; LECTIN; LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; CELL FUNCTION; CELL INTERACTION; CELL MEDIATED CYTOTOXICITY; CYTOLYSIS; HUMAN; KILLER CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TARGET CELL;

EID: 0030756727     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(97)80120-2     Document Type: Article

References (67)

1. Robertson MJ, Ritz J: Biology and clinical relevance of human natural killer cells. Blood 1990, 76:2421-2438.
2. Trinchieri G: Biology of natural killer cells. Adv Immunol 1989, 47:187-376.
3. Scott P, Trinchieri G: The role of natural killer cells in host-parasite interactions. Curr Opin Immunol 1995, 7:34-40.
4. Höglund P, Sundbäck J, Olsson-Alheim MY, Johansson M, Salcedo M, Öhlén C, Ljunggren H-G, Sentman CL, Kärre K: Host MHC class I gene control of NK-cell specificity in the mouse. Immunol Rev 1997, 155:11-28. The control of natural killer cell activity by MHC I was originally proposed by Kärre and his co-workers. This is an excellent review on the mechanisms and biological implications of the natural killer cell system.
5. Moretta L, Ciccone E, Mingari MC, Biassioni R, Moretta A: Human natural killer cells: origin, clonality, specificity and receptors. Adv Immunol 1994, 55:341-380.
6. Long EO, Colonna M, Lanier LL: Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature. Immunol Today 1996, 17:100. Important - and, so far it seems, successful - attempt to standardize the, at that time, extremely confusing nomenclature of MHC I recognizing receptors.
7. Baker E, D'Andrea A, Phillips JH, Sutherland GR, Lanier LL: Natural killer cell receptors for HLA-B allotypes, NKB1: map position 19q13.4. Chromosome Res 1995, 3:511.
8. Lanier LL, Corliss B, Phillips JH: Arousal and inhibition of human NK cells. Immunol Rev 1997, 155:145-154. Highly informative review on the regulation of human natural killer cell activity.
9. Colonna M, Samaridis J: Cloning of Ig-superfamily members associated with HLA-C and HLA-B recognition by human NK cells. Science 1995, 268:405-408.
10. D'Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL: Molecular cloning of NKB1: a natural killer cell receptor for HLA-B allotypes. J Immunol 1995, 155:2306-2310.
11. Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A, Long EO: Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995, 2:439-449.
12. •].
13. ••], who showed that the recognition of B7.1 by unknown murine natural killer receptors overcomes the inhibition by Ly-49. All these data suggest complexity in the balance between activating and inhibiting signals.
14. Colonna M, Borsellino G, Falco M, Ferrara GB, Strominger JL: HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1 - and NK2-specific natural killer cells. Proc Natl Acad Sci USA 1993, 90:12000-12004.
15. Mandelboim O, Reybum HT, Vales-Gomez M, Pazmany L, Colonna M, Borsellino G, Strominger JL: Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med 1996, 184:913-922. Interesting structural work showing that recognition of HLA-C does not necessarily require the presence of peptides. The data raise some concern about exactly which structural details of the α1 domain of HLA-C are required in the recognition by killer-cell inhibitory receptors.
16. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham O: The Bw4 public epitope of HLA-B molecules confers reactivity with NK cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995, 181:1133-1144.
17. Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO: Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 1995, 274:1016-1018.
18. •].
19. •].
20. Dohring C, Scheidegger D, Samaridis J, Cella M, Colonna M: A human killer inhibitory receptor specific for HLA-A1, A2. J Immunol 1996, 156:3098-3101. A description of the latest killer cell inhibitory receptors to be discovered, namely, the three immunoglobulin domain containing homodimers that recognize HLA-A.
21. Ryan JC, Seaman WE: Divergent functions of lectin-like receptors on NK cells. Immunol Rev 1997, 155:79-89.
22. Brown MG, Scalzo AA, Matsumoto K, Yokoyama WM: The natural killer gene complex: a genetic basis for understanding natural killer cell function and innate immunity. Immunol Rev 1997, 155:53-65. A compact description of the present knowledge on the natural killer gene complex in a nutshell. This whole volume (155) of Immunological Reviews deals with the recognition of MHC I by natural killer cells, and is highly recommended reading.
23. Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH: Human NK cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 1996, 157:4741-4745. This paper shows the association of the CD94 and NKG2 C-type lectins with each other.
24. Carretero M, Cantoni C, Bellon T, Bottino C, Biassoni R, Rodrigues A, Perez-Villar JJ, Morettal L, Moretta A, Lopez-Botet M: The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol 1997, 27:563-567. One of the first papers to demonstrate that CD94 assembles with other C-type lectins, the members of the NKG2 family, to form structures that recognize target cells, and that the heterodimer receptors can be either inhibitory or triggering.
25. Sivori S, Vitale M, Bottino C, Marcenaro E, Sanseverino L, Parolini S, Moretta L, Moretta A: CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur J Immunol 1996, 26:2487-2492.
26. Pazmany L, Mandelboim O, Valés-Gómez M, Davis DM, Reyburn HT, Strominger JL: Protection from natural killer cell- mediated lysis by HLA-G expression on target cells. Science 1996, 274:792-795. The data published in this paper may be highly relevant in the immunobiology of pregnancy. HLA-G is abundant in the trophoblast and may thus facilitate the acceptance of the fetal allograft by the mother.
27. Reyburn H, Mandelboim O, Valés-Gómez M, Sheu EG, Pazmany L, Davis DM, Strominger JL: Human NK cells: their ligands, receptors and functions. Immunol Rev 1997, 155:119-125.
28. Reyburn HT, Mandelboim O, Valés-Gómez M, Davis DM, Pazmany L, Strominger JL: The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 1997, 386:514-517. This paper is potentially of high biological relevance; it shows how viruses may adapt to the hostile natural killer cell environment. Similar results were reported in the same issue of Nature by Farrell et al. [67].
29. Raulet DH, Held W, Correa I, Dorfman J, Wu M-F, Corral L: Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 1997, 155:41-52.
30. Takei F, Brennan J, Mager DL: The Ly-49 family: genes, proteins, and recognition of class I MHC. Immunol Rev 1997, 155:67-78.
31. •].
32. •].
33. d, has a functional carbohydrate recognition domain. Immunity 1994, 1:785-792.
34. Kane KP: Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. J Exp Med 1994, 179:1011-1015.
35. Mason LH, Anderson SK, Yokoyama WM, Smith HRC, Winkler-Pickett R, Ortaldo R: The Ly-49D receptor activates murine natural killer cells. J Exp Med 1996, 184:2119-2128. This paper shows that murine C-type lectins can be stimulatory as well as inhibitory.
36. Brennan J, Mahon G, Mager DL, Jefferies WA, Takei F: Recognition of class I major histocompatibility complex molecules by Ly-49: specificities and domain interactions. J Exp Med 1996, 183:1553-1559. Comprehensive demonstration of the molecular mechanisms of recognition of MHC I molecules by Ly-49.
37. Correa I, Raulet DH: Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 1995, 2:61-71.
38. Orihuela M, Margulies DH, Yokoyama WM: The NK cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its MHC class I ligand. Proc Natl Acad Sci USA 1996, 93:11792-11797. An important contribution to the complex issue of the role of peptides in the recognition of MHC I by natural killer cells.
39. Chambers WH, Brissette-Storkus CS: Hanging in the balance: natural killer cell recognition of target cells. Chem Biol 1995, 2:429-435.
40. Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L: The human leukocyte antigen (HLA)-C-specific 'activatory or 'inhibitory' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 1996, 183:645-650. Pioneering work showing the structural difference between activating and inhibiting killer-cell inhibitory receptors. The term p50 for the activating receptor, as opposed to p58 for the inhibitory receptor, originates from this paper.
41. •].
42. •].
43. Houchins JP, Lanier LL, Niemi EC, Phillips JH, Ryan JC: Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol 1997, 158:3603-3609. The paper demonstrates the basic principle of the outcome of recognition by CD94: whether or not lysis occurs depends on which NKG2 chains CD94 forms heterodimeric receptors with.
44. Vivier E, Daëron M: Immunoreceptor tyrosine-based inhibition motifs. Immunol Today 1997, 18:286-291.
45. Perussia B, Starr S, Abraham S, Fanning V, Trinchieri G: Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. J Immunol 1983, 130:2133-2141.
46. Wilder JA, Koh CY, Yuan D: The role of NK cells during in vivo antigen-specific antibody responses. J Immunol 1996, 156:146-152. The evidence shows that natural killer (NK) cells can facilitate the production of IgG2a in the mouse. As IgG2a is a potent inducer of murine antibody-dependent NK cell cytotoxicity, the results suggest a positive feedback loop in the NK cell system. It remains to be studied whether the production of human IgG1, the equivalent of murine IgG2a, would be facilitated by NK cells.
47. Giorda R, Weisberg EP, Ip TK, Trucco M: Genomic structure and strain-specific expression of the natural killer cell receptor NKR-P1. J Immunol 1992, 149:1957-1963.
48. Lanier LL, Chang C, Phillips JH: Human NKR-P1A: a disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol 1994, 153:2417-2428.
49. Poggi A, Costa P, Morelli L, Cantoni C, Pella N, Spada F, Biassoni R, Nanni L, Revello V et al.: Expression of human CD34+ by immature thymocytes: NKRP1A-mediated regulation of proliferation and cytolytic activity. Eur J Immunol 1996, 26:1266-1272.
50. + and NKR-P1- rat natural killer cell clones established from NKR-P1 bright/TCRαβ- cell lines. Nat Immun 1995, 14:98-113.
51. Bezouska K, Vlahas G, Horvath O, Jinochova G, Fiserova A, Giorda R, Chambers WH, Feizi T, Pospisil M: Rat natural killer cell antigen, NKR-P1, related to C-type animal lectins is a carbohydrate-binding protein. J Biol Chem 1994, 269:16945-16952.
52. Anasetti C, Martin PJ, June CH, Hellström KE, Ledbetter JA, Rabinovitch PS, Morishita Y, Hellström I, Hansen JA: Induction of calcium flux and enhancement of cytolytic activity in natural killer cells by cross-linking of the sheep erythrocyte binding protein (CD2) and Fc-receptor (CD16). J Immunol 1987, 139:1772-1779.
53. Timonen T, Gahmberg CG, Patarroyo M: Participation of CD11a-c/CD18, CD2 and RGD-binding receptors in endogenous and interleukin-2-stimulated NK activity of CD3-negative large granular lymphocytes. Int J Cancer 1990, 46:1035-1040.
54. Chambers BJ, Salcedo M, Ljunggren H-G: Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 1996, 5:311-317. An extremely interesting paper, suggesting that B7-1 may be a target of natural killer cells. The results raise the question of when. Is B7-1 always a target, or is overexpression or perhaps redistribution (in spiky dendritic cells) required? An important paper, because it demonstrates that normal structures can trigger natural killer cell cytotoxicity.
55. Robertson MJ, Caligiuri MA, Manley TJ, Levine H, Ritz J: Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis. J Immunol 1990, 145:3194-3201.
56. Damle NK, Doyle LV, Bender JR, Bradley EC: Interleukin-2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis. J Immunol 1987, 138:1779-1785.
57. Melero I, Balboa MA, Alonso JL, Yague E, Pivel JP, Sanchez-Madrid F, Lopez-Botet M: Signalling through the LFA-1 leukocyte integrin actively regulates intercellular adhesion and tumor necrosis factor-alpha production in natural killer cells. Eur J Immunol 1993, 23:1859-1865.
58. Poggi A, Spada F, Costa P, Tomasello E, Revello V, Pella N, Zocchi MR, Moretta L: Dissection of lymphocyte function-associated antigen 1-dependent adhesion and signal transduction in human natural killer cells shown by the use of cholera or pertussis toxin. Eur J Immunol 1996, 26:967-975.
59. Pardi R, Bender JR, Dettori C, Giannazza E, Engleman EG: Heterogenous distribution and transmembrane signalling properties of lymphocyte function-associated antigen (LFA-1) in human lymphocyte subsets. J Immunol 1989, 143:3157-3166.
60. Somersalo K, Carpén O, Saksela E, Nortamo P, Gahmberg CG, Timonen T: Activation of NK cell migration by leukocyte binding peptide from ICAM-2. J Biol Chem 1995, 270:8629-8636.
61. Di Renzo L, Yefenof E, Klein E: The function of human NK cells is enhanced by beta glucan, a ligand of CD3 (CD11b/CD18). Eur J Immunol 1991, 21:1755-1758.
62. Petty HR, Todd RF III: Integrins as promiscuous signal transduction devices. Immunol Today 1996, 17:209-212.
63. Das B, Mondragon MO, Tao S-Z, Norin AJ: Preferential interaction of a novel tumor surface protein (p38.5) with naive natural killer cells. J Exp Med 1997, 185:1735-1742. This paper raises an important and probably correct point: target structures (and thus perhaps also receptors) for endogenous (circulating naive) and cytokine-activated natural killer cells may be different. Most studies are performed with natural killer cell clones, and the cytotoxic mechanism of endogenous natural killer cells has remained rather unstudied.
64. Multhoff G, Botzler C, Jennen L, Schmidt J, Ellwart J, Issels R: Heat shock protein 72 on tumor cells. A recognition structure for natural killer cells. J Immunol 1997, 158:4341-4350.
65. Helander TS, Carpén O, Turunen O, Kovanen PE, Vaheri A, Timonen T: ICAM-2 redistributed by ezrin as a target for killer cells. Nature 1996, 382:265-268. These results introduce a new concept to natural killer cell recognition: natural killer cells recognize normally structured but pathologically distributed adhesion molecules on target cell membranes.
66. Pakkanen R, von Bonsdorff C-H, Turunen O, Wahlström T, Vaheri A: Redistribution of Mr 75 000 plasma membrane protein, cytovillin, into newly formed microvilli in herpes simplex and Semliki Forest virus infected human embryonal fibroblast Eur J Biol 1988, 46:435-443.
67. Farrell HE, Vally H, Lynch DM, Fleming P, Shellam GR, Scalzo AA, Davis-Poynter NJ: Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 1997, 386:510-514.